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Cystic fibrosis (CF) pigs develop disease with features remarkably similar to those in people with CF, including 
exocrine pancreatic destruction, focal biliary cirrhosis, micro-gallbladder, vas deferens loss, airway disease, 
and meconium ileus. Whereas meconium ileus occurs in 15% of babies with CF, the penetrance is 100% in 
newborn CF pigs. We hypothesized that transgenic expression of porcine CF transmembrane conductance 
regulator (pCFTR) cDNA under control of the intestinal fatty acid–binding protein (iFABP) promoter would 
alleviate the meconium ileus. We produced 5 CFTR–/–;TgFABP>pCFTR lines. In 3 lines, intestinal expression of 
CFTR at least partially restored CFTR-mediated anion transport and improved the intestinal phenotype. In 
contrast, these pigs still had pancreatic destruction, liver disease, and reduced weight gain, and within weeks 
of birth, they developed sinus and lung disease, the severity of which varied over time. These data indicate that 
expressing CFTR in intestine without pancreatic or hepatic correction is sufficient to rescue meconium ileus. 
Comparing CFTR expression in different lines revealed that approximately 20% of wild-type CFTR mRNA 
largely prevented meconium ileus. This model may be of value for understanding CF pathophysiology and 
testing new preventions and therapies.
Introduction
Cystic fibrosis (CF) is caused by mutations in the gene encoding 
the CF transmembrane conductance regulator (CFTR). Loss of 
CFTR function causes pancreatic insufficiency, focal biliary cir-
rhosis, infertility, and recurrent and chronic airway infections that 
destroy the lung (1–3). In addition, up to 20% of babies with CF 
are born with meconium ileus (4, 5). Intestinal obstruction most 
commonly occurs in the distal ileum to proximal colon and often 
requires surgical intervention to relieve the obstruction (6, 7). The 
pathogenesis of meconium ileus remains uncertain, but may result 
from loss of CFTR-mediated Cl− and/or HCO3− transport by the 
intestinal epithelium and/or from pancreatic dysfunction (8–12).
To better understand the pathogenesis of CF, we developed a por-
cine model of CF (13–15) and found that CFTR–/– and CFTRΔF508/ΔF508 
pigs (hereafter called CF pigs) display many of the same features 
as humans with CF, including meconium ileus, exocrine pancreatic 
destruction, focal biliary cirrhosis, micro-gallbladder, vas deferens 
abnormalities, and airway disease (1, 14–17). However, in contrast 
with humans, the penetrance of meconium ileus is 100% in newborn 
CF pigs. Features of meconium ileus in CF pigs closely replicate 
those observed in humans with CF, including obstruction by meco-
nium in the distal small intestine, atretic intestinal segments, and 
microcolon (14–16). The meconium ileus in CF pigs would be lethal 
if not corrected soon after birth. In some cases, Gastrografin enemas 
can relieve meconium ileus obstruction and result in avoidance of 
surgical correction in newborn babies with CF (18, 19). However, 
attempts to nonsurgically correct the intestinal obstruction in CF 
pigs were unsuccessful, in part due to the atretic intestinal segments. 
Surgical placement of an ileostomy bypassed the obstruction, allow-
ing CF pigs to survive (14, 15, 20). Despite the ability to surgically 
treat meconium ileus in CF pigs, the procedure can be associated 
with morbidity and mortality. Moreover, surgical correction is not 
feasible in some CF pigs due to complications associated with meco-
nium ileus, including intestinal atresia and in utero intestinal perfo-
ration. That, plus the associated costs, precludes surgical correction 
as a means to obtain older CF pigs on a routine basis.
In an attempt to alleviate the meconium ileus phenotype in CF 
pigs, we were inspired by the approach of Zhou and colleagues 
(21). They used the rat intestinal fatty acid–binding protein 
(iFABP) promoter (22, 23), which is primarily expressed in the 
intestine (23), to express human CFTR in CF mice. Here, we adopt-
ed that strategy and we asked three questions. First, would express-
ing CFTR under control of the iFABP promoter prevent meconium 
ileus in CF pigs? If we observed correction, then these findings 
would help us better understand the pathogenesis of meconium 
ileus. Second, knowing that different iFABP-CFTR transgenic cell 
lines would likely have differing levels of CFTR expression, we 
asked how much CFTR function is required to prevent meconium 
ileus in CFTR–/– pigs. Finally, if this strategy alleviated the meco-
nium ileus, would these animals develop airway disease similar to 
that observed in humans with CF?
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intestinal tract, repeat Gastrografin enemas 
were performed at 8- to 12-hour intervals 
until either all of the meconium was evacu-
ated (Figure 1B) or the animals failed to pass 
meconium despite repeat enemas. Animals 
that had no or minimal meconium output 
despite good oral intake were euthanized. 
Pigs that passed meconium were transitioned 
to a piglet milk diet.
Here we report data on 15 piglets from 5 trans-
genic lines. Piglets from lines a, d, and e had 
an improved intestinal phenotype. Figure 1C 
shows images of CFTR–/–;TgFABP>pCFTR 
intestine from newborn and 6-day-old pigs 
(line a). For comparison, Figure 1C (line c) 
shows intestine from a newborn pig that had 
severe meconium ileus, like that in newborn 
CFTR–/– pigs (14, 16). Pigs from lines a, d, and 
e had less severe small intestine obstruction, 
intestinal atresia, and microcolon as well as 
greater meconium passage. In contrast, piglets 
from lines b and c did not differ from CFTR–/– 
pigs (Figure 2A). These findings indicate that 
expressing pCFTR under control of the rat 
iFABP promoter can rescue the meconium 
ileus phenotype.
CFTR is expressed and functional in the ileum 
of pigs with a rescued intestinal phenotype. These 
data suggested that differing levels of CFTR 
expression might be responsible for the vari-
able phenotypes. To test this hypothesis, we 
used quantitative RT-PCR to measure CFTR 
mRNA in ileal segments of newborn pigs. 
CFTR transcripts varied in the different lines, 
with lines a and e showing substantial CFTR mRNA, lines b and c 
showing levels not different from that of CFTR–/– ileum, and line d 
showing intermediate values (Figure 2B).
We used immunocytochemistry to localize CFTR in ileum. CFTR 
was undetectable in CFTR–/– tissue (Figure 2C). In wild-type ileum, 
CFTR localized to the apical membrane of crypt, but not villous epi-
thelia, consistent with other reports of endogenous CFTR localiza-
tion in the intestine (14, 24–26). In line e, we detected CFTR variably 
present at the apical membrane of crypt epithelial cells. Transgene-
derived CFTR expression in crypt cells is consistent with the local-
ization of CFTR in wild-type pigs and with the expression pattern 
of intestinal FABP in human intestine (14, 27). Interestingly, in mice 
transgenic for the rat iFABP promoter driving hCFTR expression, 
CFTR was localized in both the villous (21) and crypt epithelia (28).
To learn whether the recombinant pCFTR was functional, we 
excised ileal segments, mounted them in Ussing chambers, and 
assayed transepithelial currents. We added forskolin and 3-isobu-
tyl-2-methylxanthine (IBMX) to increase cellular concentrations 
of cAMP and phosphorylate and activate CFTR. Forskolin and 
IBMX increased short-circuit current (Isc) in ileal segments of 
CFTR+/+, but not typically in CFTR–/– intestine (Figure 2, D and E). 
The response varied in ileum from the different transgenic animals 
(Figure 2D). Lines a and e had ΔIscF&I responses that were approxi-
mately 60% or greater than that in wild-type ileum. Ileum from 
lines b and c lacked significant ΔIscF&I and was similar to CFTR–/– 
tissue. Line d had an intermediate ΔIscF&I response.
Results
Generation of CFTR–/–;TgFABP>pCFTR pigs. We hypothesized that 
intestinal expression of CFTR in CFTR–/– pigs would rescue the 
meconium ileus phenotype or produce a milder phenotype ame-
nable to correction with nonsurgical techniques. To express CFTR 
in the intestinal tract, we used wild-type porcine CFTR (pCFTR) 
driven by the rat iFABP gene promoter (21, 22). To produce CFTR–/– 
gut-corrected pigs (hereafter called CFTR–/–;TgFABP>pCFTR pigs), 
CFTR–/– fetal fibroblasts (male) were transfected with a rat iFABP-
pCFTR construct (Figure 1A). Antibiotic selection was performed 
followed by confirmation of positive clones with Southern blot-
ting. Positive clones were expanded and used as nuclear donors 
for transfer to enucleated oocytes. Somatic cell nuclear transfer 
embryos were transferred to surrogate females, and piglets were 
delivered at term. Five different clones (a–e) were transferred indi-
vidually to surrogate females.
The iFABP-pCFTR transgene rescues the meconium ileus phenotype 
in CFTR–/– pigs. Not knowing whether this transgenic approach 
would work, we decided to enhance the likelihood of correcting 
meconium ileus by treating the majority of animals with Gastro-
grafin enemas after birth. This strategy is used to treat meconium 
ileus in human newborns with CF (18, 19), but failed to relieve the 
intestinal obstruction in CF pigs. The response to the enema was 
variable among litters. Following the initial enema, we recovered 
either nothing, meconium pellets, or small white mucous plugs 
(∼2 mm in diameter). To enhance removal of meconium from the 
Figure 1
Intestinal FABP promoter–driven CFTR expression alleviates meconium ileus in CF pigs.  
(A) Schematic of the transgene vector with porcine CFTR cDNA driven by the rat iFABP pro-
moter (nt –1788 to +28), flanked by the intervening sequence and the bovine growth hormone 
poly-A (BGHpA) and followed by a hygromycin cDNA sequence flanked by SV40 and SV40 
poly-A signal sequences. BglI restriction site is denoted. (B) Gross image of a meconium plug 
(green-black colored portion of stool) that was passed by a CFTR–/–;TgFABP>pCFTR pig (line e) 
following an enema at approximately 18 hours after birth. A transition to normal-appearing 
stool (yellow-green stool denoted by arrow) was observed after meconium passage. Scale 
bar: 2 cm. (C) Images of the gastrointestinal tracts of CFTR–/–;TgFABP>pCFTR piglets. At 
birth, in 3 of the 5 CFTR–/–;TgFABP>pCFTR lines, meconium ileus was improved. Meconium 
ileus lesions ranged from improved (left panel, line a) with normal-sized intestine and spi-
ral colon (arrow) to severe meconium obstruction (right panel, line c, white asterisks) often 
located in the spiral colon with distal microcolon (arrow). Middle panel: gross image from the 
intestinal tract of a CFTR–/–;TgFABP>pCFTR pig (line a) at 6 days of age. The intestine and 
spiral colon (arrow) are of normal size and coloration. Scale bar: 1.3 cm.
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CFTR–/–;TgFABP>pCFTR pigs have CF-related pancreas, gallbladder, 
and liver disease. In all of these transgenic lines, we observed a 
similar degree of pancreatic destruction (Supplemental Figure 1, 
A and B; supplemental material available online with this article; 
doi:10.1172/JCI68867DS1), micro-gallbladder (Supplemental 
Figure 1, C and D), and focal biliary cirrhosis (Supplemen-
tal Figure 1E) as previously reported in newborn CFTR–/– and 
CFTRΔF508/ΔF508 pigs (14–16, 20). These findings indicate that the 
CFTR transcripts and transepithelial current correlate with rescue of 
meconium ileus. We compared mRNA levels, secretory current, and 
meconium ileus to assess the relationship between the amount of 
CFTR and the phenotype. As the abundance of CFTR transcripts 
increased, secretory current increased (Figure 3A). There was a 
similar relationship between CFTR mRNA and the meconium 
ileus phenotype (Figure 3B). These data suggest that approxi-
mately 20% of wild-type CFTR mRNA and approximately 60% of 
Cl– secretory current was sufficient to rescue the meconium ileus 
phenotype. Whereas approximately 10% of CFTR mRNA and 25% 
of wild-type CFTR-mediated anion secretion was not sufficient to 
prevent meconium ileus.
Figure 2
CFTR is expressed and functional in CFTR–/–; 
TgFABP>pCFTR piglets. (A) Range of meco-
nium ileus severity in the different CFTR–/–; 
TgFABP>pCFTR transgenic lines. Normal, 
absence of meconium ileus (CFTR+/+ intestine). 3+, 
severe meconium ileus phenotype (CFTR–/– intes-
tine). Refer to Methods for further details of scor-
ing system. (B) CFTR mRNA expression in ileal 
segments from CFTR+/+, CFTR–/–, and CFTR–/–; 
TgFABP>pCFTR newborn piglets. CFTR mRNA 
levels were determined with quantitative RT-PCR 
(relative to β-actin), and values are expressed as 
a percentage relative to CFTR+/+ mRNA levels. 
Symbols represent individual animals except for 
CFTR+/+, which is the mean. (C) CFTR localizes to 
ileal crypts (arrows). Confocal microscopy images 
show staining for β-catenin (a component of adhe-
rens junctions, red), CFTR (green), and nuclei 
(DAPI, blue). Scale bars: 10 μm. (D) Changes 
in short-circuit current (Isc) following addition of 
forskolin/IBMX (ΔIscF&I) to freshly excised ileal 
segments from newborn CFTR+/+, CFTR–/–, and 
CFTR–/–;TgFABP>pCFTR piglets. Prior to for-
skolin/IBMX treatment, tissues were exposed to 
amiloride. Symbols represent individual animals. 
Line represents mean ± SEM. (E) Representative 
Isc tracings from freshly excised ileal segments 
mounted in Ussing chambers for electrophysi-
ological studies. Ileal samples were obtained from 
newborn piglets. The following agents were added 
sequentially: apical 100 μM amiloride (amil), apical 
10 μM forskolin/100 μM IBMX (F/I), apical 100 μM 
GlyH, basolateral 100 μM carbachol (CCH), apical 
100 μM DIDS, apical 5 mM dextrose (Dex), and 
apical 200 μM phlorizin (Phz).
Figure 3
CFTR expression and secretory current correlate with meconium ileus 
phenotype. (A) Ileal ΔIscF&I versus ileal CFTR mRNA levels in the dif-
ferent CFTR–/–;TgFABP>pCFTR lines. (B) Meconium ileus severity ver-
sus ileal CFTR mRNA levels in the different transgenic lines. Data are 
shown as a percentage of wild-type levels (CFTR+/+ [+/+]). –/–, CFTR–/– 
animals. Individual labels denote the different cell lines.
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current. Moreover, these data are quantitatively similar to those we 
previously reported for upper and lower airways in CF and non-CF 
pigs (30). These data indicated that the iFABP-pCFTR transgene gen-
erates no appreciable CFTR expression in the proximal airways and 
suggested that the transgenic pigs might develop airway disease.
CFTR–/–;TgFABP>pCFTR pigs survive without surgical correction of 
meconium ileus. To determine whether CFTR–/–;TgFABP>pCFTR pigs 
would develop lung disease, we followed 6 transgenic CF pigs for 3 or 
more weeks (Supplemental Table 1). Case nos. 1–3 were treated with 
Gastrografin enemas at birth and case nos. 4–6 survived without an 
enema. Similar to CFTR–/– pigs and gut-corrected CF mice (31, 32), 
CFTR–/–;TgFABP>pCFTR pigs had reduced growth (Figure 5A). 
These data suggest that the growth defect in CF pigs is not depen-
dent upon intestinal CFTR expression (32). We euthanized pigs 
when they developed signs of respiratory disease or complications 
of gastric ulcer or at planned time points.
iFABP-pCFTR transgene did not correct other digestive system 
manifestations of CF.
CFTR is not present in the airways of CFTR–/–;TgFABP>pCFTR pigs. In 
rodents, expression of the endogenous iFABP gene is most abun-
dant in the intestinal tract (23). However, when human CFTR was 
expressed under control of the rat iFABP promoter in CFTR-null 
mice, some lines exhibited extra-intestinal human CFTR expres-
sion, including in the lungs (21). On gross examination, trache-
as from all 5 CFTR–/–;TgFABP>pCFTR lines had narrowed airway 
lumens, cartilaginous ring defects, and abnormal-appearing air-
way smooth muscle bundles, as we previously observed in neonatal 
CF pigs and humans with CF (Figure 4A and ref. 29).
To further test for CFTR function, we harvested fresh tracheal tissue 
from newborn pigs, mounted the excised tissue in Ussing chambers, 
and measured transepithelial currents. We added amiloride to block 
epithelial Na+ channels and 4,4-diisothiocyanostilbene-2,2-disulfonic 
acid (DIDS) to block non-CFTR Cl− channels. Subsequent addition 
of forskolin and IBMX increased Isc in CFTR+/+ tracheas, but failed to 
substantially increase Isc in CFTR–/– or any of the tracheas from the 
CFTR–/–;TgFABP>pCFTR lines (Figure 4B and Supplemental Figure 
2B). We obtained qualitatively similar results with cultured tracheal 
epithelia (Figure 4C) and nasal turbinate epithelium (Supplemental 
Figure 2C), including the lack of cAMP-stimulated transepithelial Cl− 
Figure 4
CFTR–/–;TgFABP>pCFTR pigs lack CFTR-mediated electrolyte trans-
port in the airways. (A) Microscopic images of trachea from a CFTR–/–; 
TgFABP>pCFTR newborn pig. The tracheas were irregularly shaped, 
had cartilage ring defects in the anterior trachea (top panel, arrow), 
and areas of abnormal-appearing airway smooth muscle bundles (bot-
tom panel, arrows) (30). Scale bars: 820 μm (top panel); 82 μm (bot-
tom panel). (B) Changes in short-circuit current (Isc) following addition 
of forskolin/IBMX (ΔIscF&I) to freshly excised tracheal segments from 
newborn CFTR+/+, CFTR–/–, and CFTR–/–;TgFABP>pCFTR piglets. (C) 
ΔIscF&I in cultured tracheal epithelia from newborn CFTR+/+, CFTR–/–, 
and CFTR–/–;TgFABP>pCFTR piglets (no sample was available for line 
d). Prior to forskolin/IBMX treatment, tissues were sequentially exposed 
to amiloride and DIDS. Symbols represent individual animals. Line rep-
resents mean ± SEM. Data for lines b, d, and e in B and line e in C did 
not differ significantly from data for CFTR–/–.
Figure 5
CFTR–/–;TgFABP>pCFTR pigs develop airway disease postnatally. (A) 
Both CFTR–/– (white circles: n = 5) and CFTR–/–;TgFABP>pCFTR (gray 
circles: n = 6) pigs gained less weight than did non-CF pigs (black cir-
cles: CFTR+/+, n = 5; CFTR+/–, n = 1). Data are mean ± SEM. *P < 0.01 
for both CF and gut-corrected CF pigs compared with non-CF pigs. 
(B) Microscopic image of the pancreas from case no. 3. Pancreas was 
composed mostly of adipose tissue (asterisks) with sparse remnant 
pancreatic tissue and intact islets (arrows). (C) Sinus x-ray CT image 
from a CFTR–/–;TgFABP>pCFTR pig (case no. 4) at approximately 
3 weeks of age. Bilateral ethmoid sinus opacification (arrows) was 
present on the sinus CT scan. (D) Case no. 4, severe sinus disease 
with mucopurulent material obstructing the sinus lumen with submuco-
sal (Bowman’s) gland hypertrophy. dPAS stain. (E) Case no. 4, mucopu-
rulent debris obstructing a small bronchiole. H&E stain. (F) Case no. 4, 
bronchus with goblet cell hyperplasia. dPAS stain. Scale bars: 167 μm 
(B); 90 μm (D); 87 μm (E); 29 μm (F).
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mucocellular exudate (Figure 5C and Supplemental Figure 5A). 
Histopathological examination showed neutrophils and abun-
dant mucus obstructing the air space (Figure 5D, Supplemental 
Figure 5, B and D, and Supplemental Figure 4B). Within the core 
of mucocellular debris, mixed populations of Gram-positive and 
Gram-negative bacterial colonies were often detected, as well as 
rare fungal elements (Supplemental Figure 5, E and F).
The tracheas were irregularly shaped, defects in the cartilage 
rings were present, and airway smooth muscle bundles appeared 
enlarged and prominent (Supplemental Figure 6). These find-
ings are similar to those we previously reported for CF pigs (29). 
The lungs were affected in a heterogeneous pattern with mucus 
accumulation often centered on small bronchi to bronchioles. 
The abnormal airway mucus lesions ranged from mild lining of 
airways to completely obstructive changes, with mucocellular 
obstructions and concurrent atelectasis of lung tissues (Figure 5, E 
and F, Supplemental Figure 7, A–F, and Supplemental Figure 4C). 
Histopathologic examination of the liver from older pigs revealed 
heterogeneous changes ranging from focal biliary cirrhosis to 
bridging changes indicative of multilobular cirrhosis (Supplemen-
tal Figure 3A). The pancreas showed evidence of progressive exo-
crine tissue loss and replacement by adipose tissue with prominent 
dilated ducts and acini (Figure 5B, Supplemental Figure 3B, and 
Supplemental Figure 4A), similar to that found in older CFTR–/– 
and CFTRΔF508/ΔF508 pigs (15, 20). The gallbladders were small and 
variably filled with mucopurulent and necrotic cellular debris or 
mucus and inflammatory cells (Supplemental Figure 3C). We also 
observed variable changes along the length of the vas deferens; in 
some areas, the lumen was collapsed and filled with eosinophilic 
material that was PAS-positive, but more commonly the lumen was 
completely absent (Supplemental Figure 3D).
CFTR–/–;TgFABP>pCFTR pigs develop airway disease similar to that in 
humans with CF. At necropsy, ethmoid sinuses were a common site 
of obstructive disease and frequently contained thick, tenacious 
Figure 6
Airway disease is dynamic in CFTR–/–; 
TgFABP>pCFTR pigs. (A) Serial chest x-ray 
CT images from a CFTR–/–;TgFABP>pCFTR 
pig (case no. 3). Airway wall thickening (arrows) 
was present. At 3 months, obstruction of the 
tracheal bronchus was observed, with collapse 
of the associated lung segment (asterisks). 
This persisted until 9 months and was resolv-
ing by 10 months. Airway wall thickening and 
parenchymal changes persisted. (B–D) Serial 
tracheal lobe BAL samples from 2 CFTR–/–; 
TgFABP>pCFTR pigs (case no. 3, left panels) 
(case no. 2, right panels). (B) Total number and 
different bacterial species recovered in the BAL 
liquid. Data are color coded to indicate individ-
ual species of bacteria. Percentage of neutro-
phils (C) and IL-8 levels (D) were determined 
on recovered liquid from the tracheal lobe BAL.
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most mortality in CF mice occurs at the time of weaning, and only a 
small fraction die from intestinal disease shortly after birth. Trans-
genic expression of CFTR repairs the phenotypes in mice (21, 28, 31) 
and pigs, and in a preliminary report, in ferrets (39). These results 
suggest that both meconium ileus and DIOS are caused by loss of 
intestinal CFTR anion transport. However, the data do not indicate 
that the pathogenic mechanisms are the same for the 2 manifes-
tations. Understanding the mechanisms of meconium ileus will 
require studies at the time when it is developing in the fetus.
CFTR–/–;TgFABP>pCFTR pigs develop lung disease similar to that in 
human CF. Although tissue-specific promoters can drive transgene 
expression at unintended tissue sites, our electrophysiological and 
histopathological studies indicate that the airways of the trans-
genic CF pigs developed disease like that seen in nontransgenic 
CF pigs (15, 20, 36).
We previously reported that CF airway disease can vary over time 
(15, 20), and one of the CFTR–/–;TgFABP>pCFTR pigs (case no. 3) 
provided a striking example of spontaneous variation in the sever-
ity of airway disease. Although the use of antibiotics and limita-
tions of assays prevent such tracking in humans, these findings 
may have a counterpart in human CF. People with CF can manifest 
long periods of time with minimal or absent pulmonary symp-
toms, and there can be extended periods between exacerbations 
of pulmonary disease (41–43). These time-dependent variations 
suggest that not all host defense is disrupted by loss of CFTR. For 
example, we recently found that lack of CFTR-mediated HCO3– 
transport and a decreased pH reduced, but did not abolish, bacte-
rial killing by airway surface liquid antibacterials in CF pigs (44). 
The variation in bacterial species cultured from the CF lungs is 
also consistent with our earlier observations that the CF host 
defense defect does not favor a specific bacterial species (20).
There is a relationship between CFTR expression and the meconium 
ileus phenotype. With the development of CFTR-targeted therapies 
using either genetic or small molecule approaches, an important 
but unanswered question is how much CFTR is required to either 
alleviate or cure the disease. We recently showed that CFTRΔF508/ΔF508 
pigs develop lung disease like humans with CF, despite an apical 
membrane Cl– conductance approximately 6% of wild-type values 
(15). Those data suggest that more than 6% of wild-type CFTR 
channel function is required to prevent lung disease. Our current 
data indicate that approximately 10% of wild-type CFTR transcripts 
had a minor effect, but was insufficient to correct the meconium 
ileus phenotype. These values from airway and intestine are in rea-
sonable agreement. We also found that approximately 20% of wild-
type CFTR mRNA largely corrected the meconium ileus.
The approximately 10% and 20% of wild-type CFTR transcript 
levels translate to cAMP-stimulated short-circuit current of 
approximately 25% and 60%, respectively. Note, however, that the 
short-circuit current measurements depend on basolateral mem-
brane transport processes and other mechanisms in addition to 
CFTR. Thus, those values cannot be taken to mean that the epithe-
lium had approximately 25% and 60% of CFTR function.
Comparisons between CFTR expression and correction of the 
meconium ileus phenotype have advantages and caveats. The 
advantages are as follows: (a) the site of CFTR expression in the 
crypts matches that of endogenous CFTR; (b) in contrast with 
previous studies in cultured airway epithelia in which a variable 
fraction of cells had wild-type CFTR expression (45) or CFTR over-
expression (46), in this study, the population of cells expressed a 
variable fraction of wild-type CFTR; (c) we compared the percent-
While wispy mucus was occasionally detected lining larger airways 
in non-CF pigs, the nature and extent of the luminal mucus were 
distinct in CF pigs. The airway mucus of CF pigs frequently had 
lamellar to stringy appearance that sometimes appeared in small 
airways such as bronchioles that lacked overt mucinous change of 
the lining epithelium (Supplemental Figure 7F). In larger airways, 
the mucus lined the surface epithelium, which had multifocal gob-
let cell hyperplasia and mucus filling of submucosal gland ducts 
(Figure 5F and Supplemental Figure 7, A–D).
To follow the course of lung disease, we performed serial chest 
x-ray CT imaging and bronchoalveolar lavage (BAL) in 2 longer-
lived CFTR–/–;TgFABP>pCFTR pigs. Lung disease tended to be 
radiographically most evident in the tracheal lobe (Figure 6A). 
Evidence of persistent airway wall thickening was detected at 
2 months of age. Radiographic changes were variably present over 
time, including patchy infiltrates and collapse of a tracheal lobe 
subsegment (Figure 6A). These findings are consistent with find-
ings observed in human CF lungs (33).
Culture of BAL liquid showed variable numbers and species of 
bacteria over time (Figure 6B and Supplemental Figure 8). Consis-
tent with our earlier studies of CF pigs (20), in case no. 2, we did 
not detect substantial BAL changes. Of note, at 3 different time 
points, BAL liquid from case no. 3 contained Pseudomonas aeru-
ginosa (Figure 6B), an organism often isolated from human CF 
lungs (34, 35) and that we have previously isolated from porcine 
CFTR–/– sinus (36). The absolute numbers of P. aeruginosa changed 
over time, and not all subsequent samples were positive. In case no. 
3, the waxing and waning numbers of BAL bacteria and chest CT 
abnormalities were paralleled by an increase and decrease in the 
percentage of neutrophils and IL-8 levels in BAL liquid (Figure 6, 
C and D). Interestingly, these changes occurred spontaneously 
despite lack of antibiotic use.
Discussion
CFTR expression in the intestine is sufficient to rescue meconium ileus in 
CF pigs. Finding that transgenic expression of CFTR induced anion 
transport in the newborn ileum and rescued the meconium ileus 
phenotype suggests that correcting Cl− and/or HCO3− transport 
across intestinal epithelia is sufficient to prevent meconium ileus. 
Moreover, intestinal CFTR expression prevented meconium ileus 
despite the presence of pancreatic disease. Thus, although there 
is a strong association between the occurrence of meconium ileus 
and pancreatic insufficiency (12, 37), that link is likely related to 
the presence of more severe CFTR mutations rather than to a caus-
al role for pancreatic exocrine insufficiency in meconium ileus.
It is interesting to compare CF intestinal disease in humans, pigs, 
mice, and ferrets and the effect of an iFABP-pCFTR transgene. In 
humans, up to 20% of newborns have meconium ileus, and later in 
life, some people with CF develop distal intestinal obstruction syn-
drome (DIOS), an acute complete or incomplete fecal obstruction in 
the ileocecal region (38). It has been estimated to occur with an inci-
dence of 6.2 episodes per 1000 patient-years and is usually treated 
conservatively. In CF pigs, intestinal disease resembles meconium 
ileus in humans with development in utero, occasional intestinal 
perforation prior to birth, and atretic bowel distal to the obstruc-
tion (7, 14–16). In addition, after the meconium ileus has been sur-
gically bypassed, CF pigs may also develop a DIOS-like syndrome 
(14). Approximately 75% of CF ferrets are also reported to develop 
meconium ileus (39). In contrast, most CF mouse models have an 
intestinal phenotype resembling severe DIOS (40). For example, 
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(Invitrogen) for 14 days to select for antibiotic-resistant clones. Southern 
blot screening was performed on Hygromycin-resistant cells as previously 
described (13). Briefly, amplified whole genomic DNA was prepared from 
each clone and 20 μg was digested with BanII overnight. Genomic digests 
were electrophoresed on a 0.8% agarose gel and transferred to a positively 
charged nylon membrane (Roche) using an alkaline transfer procedure. 
Blots were prehybridized for 30 minutes at 65°C in Rapid-hyb buffer 
(Amersham). The blot was then hybridized in Rapid-hyb buffer with a 
32P-labeled probe specific for the entire exon 13 of porcine CFTR (65°C, 
overnight). Two bands were anticipated on the blots: one at 2198 bp for 
endogenous CFTR and the other at 3542 bp for the transgenic CFTR.
Production of transgenic animals. Cryopreserved clones were thawed and 
resuspended in micromanipulation medium. Oocyte maturation, somatic 
cell nuclear transfer, surrogate preparation, and embryo transfer were all 
performed as previously described (13, 49–53).
Care of pigs. Piglets were delivered either via cesarean section on days 116–118 
or naturally. After delivery, the piglets received colostrum. Some piglets 
received polyethylene glycol 3350 (Perrigo) orally. Shortly after birth, most 
piglets underwent a Gastrografin enema. This was repeated every 8–12 hours 
until all meconium was evacuated or the enemas failed to induce a response. 
Piglets were transitioned to milk replacer until mature enough to be placed 
on standard pig diets. In some litters, piglets received daily antibiotics for the 
first 7–14 days of life. All animals received oral pancreatic enzyme replace-
ment therapy with meals and an oral proton pump inhibitor once a day.
BAL liquid collection and analysis. For BAL in the older pigs, animals were 
anesthetized with ketamine (15–20 mg/kg, i.m.), xylazine (1–1.5 mg/kg, 
i.m.), and intravenous propofol. A flexible fiber optic bronchoscope (Pen-
tax FB-10X) was inserted orally and passed through the vocal cords. The 
suction channel was not used until the tip of the bronchoscope was past 
the vocal cords. The bronchoscope tip was gently inserted and wedged into 
the tracheal bronchus airway for all animals. Three aliquots (10 ml each) of 
sterile saline were instilled into the airway and lavage liquid was recovered 
with intermittent suction. The BAL liquid was pooled and immediately 
placed on ice, transported to the laboratory for processing (cell counts and 
microbiology studies), and stored at –80°C for subsequent analysis.
The total number of recovered cells in BAL liquid was quantified with a 
hemacytometer, and morphologic differentiation of cells was performed on 
cytospin preparations that were stained with Diff-Quik Stain Kit (Baxter). 
Microbiologic studies were performed on collected BAL liquid. IL-8 levels 
were determined on recovered supernatant after centrifugation (1600 g for 
10 minutes) using a standard sandwich ELISA (R&D Systems).
CT scanning. All sinus and chest x-ray CT imaging was performed on 
sedated, spontaneously breathing animals using a 64-slice high-resolution 
CT (HRCT) scanner (SOMATOM 64; Siemens).
Production of primary cultures of differentiated airway epithelia. Epithelial 
cells were isolated from tracheas and nasal turbinates by enzymatic diges-
tion, seeded onto permeable filter supports, and grown at the air-liquid 
interface as previously described (54). Differentiated epithelia were used 
at least 14 days after seeding.
Histopathologic analysis. At necropsy, pigs were examined for gross lesions, 
and the findings were documented. Tissues were collected and fixed in 10% 
neutral buffered formalin usually for 48–96 hours. Tissues were then rou-
tinely processed, embedded, sectioned (∼4 μm), and stained with routine 
histochemical stains such as H&E for general examination. Special stains 
were selected for specific tissues/lesions and included amylase-pretreated 
PAS (dPAS), Gomori methenamine silver (GMS) stain, modified Gram 
stain, and Masson trichrome.
Meconium ileus scoring system. At necropsy, meconium ileus severity was 
scored by an investigator with substantial expertise in the gastrointes-
tinal phenotype of newborn CF pigs. The following scoring system was 
age of wild-type CFTR transcripts to a clinical phenotype rather 
than solely to an electrophysiological assay; (d) examining this 
relationship in CFTR-null pigs has the advantage that potential 
variations in processing of CFTR-ΔF508 do not introduce a con-
founding variable. Caveats include the following: (a) we focused on 
CFTR function in the ileum since the meconium ileus obstruction 
most commonly occurs in that intestinal segment (47); however, 
because the in utero pathogenesis of meconium ileus is unknown, 
it remains possible that CFTR function in other portions of the 
intestine might be more important for meconium ileus; (b) our 
estimates are derived from CFTR–/– pigs and not humans with CF; 
although the porcine meconium ileus phenotype is very similar 
to that observed in humans, its penetrance is much greater than 
in humans (100% vs. 15%–20%) (14–16, 19); thus, intestinal anat-
omy, physiology, or genetic modifiers might differ in pigs and 
humans and thereby alter the relationship between CFTR func-
tion and meconium ileus severity; (c) our studies were conducted 
on newborn tissue, and we cannot say how much CFTR function 
is required during intestinal development.
The question about the amount of CFTR required to prevent 
intestinal disease was also tested by Dorin and colleagues (48). 
They crossed mouse models with different CFTR alleles that 
retained some CFTR expression. They suggested that approxi-
mately 5% of wild-type CFTR expression and approximately 20% 
of CFTR Isc was sufficient to almost completely rescue survival 
from intestinal disease. Those values are lower than our findings, 
perhaps because of differences in phenotype, meconium ileus ver-
sus DIOS, and/or perhaps because of other species differences.
Our results indicate that expressing CFTR in the intestine res-
cued the meconium ileus phenotype. Moreover, the CFTR–/–; 
TgFABP>pCFTR pigs had pancreatic, liver, gallbladder, vas deferens, 
sinus, and lung disease comparable to that previously reported for 
CFTR–/– and CFTRΔF508/ΔF508 pigs (15–18, 21, 30, 36). This method 
offers a practical alternative to surgery for selectively correcting meco-
nium ileus and thus may produce animals useful in understanding 
CF pathophysiology and testing new preventions and therapies.
Methods
CFTR–/–;TgFABP>pCFTR vector construction. For generation of CFTR–/–; 
TgFABP>pCFTR pigs, we transfected CFTR–/– fetal fibroblasts with a trans-
genic construct containing the rat iFABP promoter (a gift from Jeffrey Gor-
don, Washington University, St. Louis, Missouri, USA) and porcine CFTR. 
Using the pCI vector (Promega), we first substituted the CMV promoter 
with the nucleotide sequence –1788 to +28 of the rat iFABP promoter. The 
porcine CFTR sequence was amplified from pcDNA3.1-Kozak-pCFTR plas-
mid using NheI and Xho1 and inserted into the redesigned pCI-iFABP vec-
tor with the same enzymes. Plasmid pcDNA3.1(+)Hygro (Invitrogen) was 
digested with NruI and EcoRV to remove the CMV promoter (pcDNA3.1(+)
HygroΔCMV). The iFABP-CFTR fragment was amplified from pCI-iFABP-
pCFTR with PfuUltra Polymerase (Stratagene) and ligated with pcDNA3.1(+)
HygroΔCMV. Restriction and sequence analysis were performed on the rede-
signed plasmid prior to use for transfection of fetal fibroblasts.
Fetal fibroblasts. We previously reported generation of CFTR–/– pigs (14). 
Fetal fibroblasts were isolated from day 35 CFTR–/– fetuses as previously 
described (13, 48). Cells were grown in F10 medium (Invitrogen) contain-
ing 20% FCS and penicillin/streptomycin.
Transfection, selection, and Southern blot screening of clones. Fetal CFTR–/– 
fibroblasts were electroporated with 15 μg of linearized DNA from the 
iFABP-pCFTR transgenic construct and then cultured. After 48 hours, the 
medium was changed and supplemented with 100 μg/ml Hygromycin 
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Trachea and cultured airway epithelia were bathed on both surfaces with 
solution containing the following: 135 mM NaCl, 2.4 mM K2HPO4, 0.6 mM 
KH2PO4, 1.2 mM CaCl2, 1.2 mM MgCl2, 10 mM dextrose, 5 mM HEPES, 
pH 7.4 (NaOH), at 37°C and gassed with compressed air. A standard pro-
tocol was the following: (a) measurements under basal conditions; (b) api-
cal 100 μM amiloride to inhibit ENaC Na+ channels; (c) apical 100 μM 
DIDS to inhibit most anion channels other than CFTR; (d) apical 10 μM 
forskolin and 100 μM IBMX to increase cellular levels of cAMP leading to 
phosphorylation and activation of CFTR; (e) apical 100 μM GlyH-101 (a 
gift from the Cystic Fibrosis Foundation Therapeutics and Robert Bridges, 
Rosalind Franklin University of Medicine and Science, North Chicago, Illi-
nois, USA) to inhibit CFTR; and (f) basolateral 100 μM bumetanide to 
inhibit Na-K-2Cl transporter.
Ileum was bathed on both surfaces with a solution containing the fol-
lowing: 118.9 mM NaCl, 2.4 mM K2HPO4, 0.6 mM KH2PO4, 1.2 mM CaCl2, 
1.2 mM MgCl2, and 25 mM NaHCO3 at 37°C and gassed with 5% CO2/air 
balance. A standard protocol was the following: (a) measurements under 
basal conditions; (b) apical 100 μM amiloride; (c) apical 10 μM forskolin 
and 100 μM IBMX; (d) apical 100 μM GlyH-101; (e) basolateral 100 μM 
carbachol; (f) apical 100 μM DIDS; (g) apical 5 mM dextrose was added to 
assess tissue viability, and (h) apical 200 μM phlorizin was added to block 
sodium/glucose transport.
Statistics. Data are presented for individual animals and as means ± SEM. 
For comparisons between 2 or more groups, the Kruskal-Wallis ANOVA 
using Dunn’s post-test or 1-way ANOVA using Tukey’s post-test was used 
for nonparametric and parametric data, respectively. Differences were con-
sidered statistically significant at P < 0.05.
Study approval. The University of Iowa and University of Missouri Animal 
Care and Use Committees approved all animal studies.
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employed: 3+, no correction of meconium ileus phenotype (newborn piglet 
failed to pass meconium spontaneously; intestinal diverticuli, intestinal 
atresia, and microcolon were present); 2+, mild correction of meconium 
ileus phenotype (newborn piglet failed to pass significant meconium spon-
taneously; less severe intestinal diverticuli, intestinal atresia, and microco-
lon compared with 3+ group); 1+, moderate correction of meconium ileus 
phenotype (some newborn piglets passed meconium spontaneously; less 
severe intestinal diverticuli, intestinal atresia, and microcolon compared 
with 2+ group but not completely normal as compared with wild-type pigs); 
normal: no meconium ileus phenotype (all newborn piglets pass meconium 
spontaneously; no intestinal diverticuli, intestinal atresia, or microcolon).
Microbiologic studies. Standard microbiologic techniques were utilized to 
identify and quantify bacteria present in BAL liquid samples. Samples were 
serially diluted and plated onto blood agar (tryptic soy agar with sheep 
blood; Remel), Colombia colistin-nalidixic acid agar (Remel), chocolate 
agar (Remel), mannitol salt agar (Remel), MacConkey agar (Remel), and 
Burkholderia cepacia selective agar (Remel). Organisms were identified with 
standard microbiological procedures. Some identifications were con-
firmed by API 20E or API 20NE (bioMérieux), Vitek (bioMérieux), or 16S 
rRNA gene sequencing (University of Iowa Clinical Microbiology Labora-
tory and Iowa State University Diagnostic Laboratory).
Quantitative RT-PCR. Quantitative RT-PCR used TaqMan chemistry 
and an ABI 7500 Fast Real-Time PCR System to measure porcine CFTR 
mRNA. Briefly, tissue was collected in RNAlater (Ambion), and total RNA 
was isolated. First-strand cDNA was synthesized with random hexamers 
(SuperScript III). Sequence-specific primers and probes for porcine CFTR 
and β-actin were from ABI. For measuring CFTR mRNA, primer/probe 
sets annealing to exon 10 of CFTR (Ss03389420_m1, pCFTR) and β-actin 
(Ss03376160_u1, ACTB) were used in separate reactions. CFTR mRNA lev-
els were normalized to β-actin. This normalized value for each tissue (ileum 
or trachea) was expressed relative to normalized CFTR+/+ tissues to calcu-
late the percentage of mRNA relative to wild-type levels (100%).
Immunocytochemistry. Intestinal tissues were excised from newborn piglets, 
fixed 1 hour at room temperature in 2% paraformaldehyde, and then kept 
overnight in ice-cold 30% sucrose before quick-freezing in OCT in an ethanol/
dry ice bath. Tissue segments were kept at –80°C. Tissues were cryosectioned 
into 7-μm sections, permeabilized in 0.2% Triton X-100 (Thermo Fisher) in 
PBS, and blocked in Super-Block (Thermo Fisher) with 5% normal goat serum 
(Jackson ImmunoResearch Laboratories). Tissue sections were incubated for 
2 hours at 37°C in anti-CFTR antibody 596 (CF Folding Consortium) and 
polyclonal antibody to β-catenin (Invitrogen; Zymed) (all at 1:100 dilution), 
followed by secondary antibodies (goat anti-mouse Alexa Fluor 488 and goat 
anti-rabbit Alexa Fluor 568 (Molecular Probes;Invitrogen) (1:1000 dilution). 
Sections were mounted with Vectashield containing DAPI (Vector Labora-
tories) to visualize nuclei. Images were acquired on an Olympus Fluoview 
FV1000 confocal microscope with a UPLSAPO ×60 oil lens. Images were 
scanned sequentially at 2 ms/pixel. Figure 2C represents acquired Z-series.
Electrophysiological measurements of freshly excised tissues and cultured airway epithe-
lia. Epithelial tissues were excised from the nasal turbinate, trachea, and ileum 
immediately after animals were euthanized. Tissues and cultured epithelia 
were studied in modified Ussing chambers (EasyMount Ussing Chamber Sys-
tem; Physiologic Instruments). For excised tissues, a chamber with a 2-mm 
diameter aperture was used. Transepithelial voltage was maintained at 0 mV 
to measure short-circuit current (Isc) (VCC MC-8; Physiologic Instruments).
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